This global Infectious Disease Point-of-care Diagnostics Market report is generated based on the market type, size of the organization, availability on-premises and the end-users’ organization type. The current market scenario and future prospects of the sector have also been examined in the most excellent Infectious Disease Point-of-care Diagnostics Market report. It is a professional and detailed report that highlights primary and secondary drivers, market share, leading segments and geographical analysis. The report also analysis the emerging trends along with major drivers, challenges and opportunities in the Infectious Disease Point-of-care Diagnostics Market.
The global infectious disease point-of-care diagnostics market size was USD 1.12 billion in 2020.The market is projected to grow from USD 1.3 billion in 2021 to USD 3.96 billion in 2028 at a CAGR of 17.2% in the 2021-2028 period. The sudden rise in CAGR is attributable to this market’s demand and growth, returning to pre-pandemic levels once the pandemic is over.
Get Sample PDF with Latest Trends:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/104307
Key players covered in the global Infectious Disease Point-of-care Diagnostics Market research report:
- F. Hoffmann-La Roche Ltd (Basel, Switzerland)
- Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
- Abbott Laboratories (Illinois, U.S)
- Quest Diagnostics Incorporated (New Jersey, United States)
- BD (Franklin Lakes, U.S)
- bioMérieux SA (Marcy l'Etoile, France)
- Cardinal Health, Inc. (Ohio, U.S)
- Mesa Biotech (California, U.S)
- Cepheid (California, U.S)
- Trinity Biotech (Bray, Ireland)
- Quidel Corporation (San Diego, U.S.)
- Bio-Rad Laboratories Inc. (California, U.S)
- Other Players
Drivers & Restraints
Globally, the increasing prevalence of HIV/Influenza/RSV, etc., leads to an increase in the rate of diagnosis of patients. For instance, according to the United Nations Program on HIV/AIDS (UNAIDS), in 2019, approximately 38 million people were diagnosed with HIV/AIDS. Furthermore, according to another report published by the World Health Organization (WHO), in the year 2018, around 10 million people were affected by tuberculosis worldwide. Thus, the growing infection rate of the various diseases globally will lead to an increase in the uptake of infectious disease point of care products for its diagnosis and subsequently aid the growth of the market during the forecast period.
Some Key Findings of the Global Infectious Disease Point-of-care Diagnostics Market Report Include:
- The analysis includes a global Infectious Disease Point-of-care Diagnostics Market study, expansions, and forecasts, along with a country-specific analysis.
- The study also offers complex measures of potential market effect during the forecast period and an in-depth overview of the leading companies operating in the global market.
- The report helps to understand the effects of COVID-19 pandemic on global Infectious Disease Point-of-care Diagnostics Market.
- Product offering details on competitive benchmarking and evolution approach adopted by the industry players.
To Purchase Report, Click Here:
https://www.fortunebusinessinsights.com/checkout-page/104307
Related Reports: